Silver Book Fact

Baseline lung cancer screening would lead to more than 130,000 additional survivors in 2012.

Pyenson, Bruce S., Marcia S. Sander, Yiding Jiang, Howard Kahn, and James L. Mulshine. An Actuarial Anaylsis Shows That Offering Lung Cancer Screening As An Insurance Benefit Would Save Lives At Relatively Low Cost. Health Affairs. 2012; 31(4): 770-779

Reference

Title
An Actuarial Anaylsis Shows That Offering Lung Cancer Screening As An Insurance Benefit Would Save Lives At Relatively Low Cost
Publication
Health Affairs
Publisher
Project HOPE
Publication Date
2012
Authors
Pyenson, Bruce S., Marcia S. Sander, Yiding Jiang, Howard Kahn, and James L. Mulshine
Volume & Issue
Volume 31, Issue 4
Pages
770-779

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Drugs like bevacizumab- designed to impede the growth of blood vessels and tumors- can cost more than $100,000 per patient.   
  • The 1-year survival rate for lung cancer has increased from 37% in 1975 to 42% in 1999-2001, largely because of improvements to surgical techniques and with combined therapies.  
  • Cervical cancer screening reduces incidence by over 80%.  
  • Every additional dollar spent on overall breast cancer treatment has produced health gains valued at $4.80.  
  • A drug for testicular cancer that cost an estimated $56 million to develop led to a sharp increase in survival rate and an annual return of $166 million in treatment…